1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Chagas Disease (American Trypanosomiasis) Global Clinical Trials Review, H2, 2016

Chagas Disease (American Trypanosomiasis) Global Clinical Trials Review, H2, 2016

Summary

GlobalData's clinical trial report, “Chagas Disease (American Trypanosomiasis) Global Clinical Trials Review, H2, 2016" provides an overview of Chagas Disease (American Trypanosomiasis) clinical trials scenario. This report provides top line data relating to the clinical trials on Chagas Disease (American Trypanosomiasis). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Chagas Disease (American Trypanosomiasis) Global Clinical Trials Review, H2, 2016
Table of Contents
Table of Contents 2


Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Five Countries Contributing to Clinical Trials in Central and South America 12
Clinical Trials by G7 Countries: Proportion of Chagas Disease (American Trypanosomiasis) to Infectious Disease Clinical Trials 13
Clinical Trials by Phase in G7 Countries 15
Clinical Trials by E7 Countries: Proportion of Chagas Disease (American Trypanosomiasis) to Infectious Disease Clinical Trials 16
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Chagas Disease (American Trypanosomiasis) Therapeutics Clinical Trials 27
Prominent Drugs 28
Clinical Trial Profile Snapshots 29
Appendix 43
Abbreviations 43
Definitions 43
Research Methodology 44
Secondary Research 44
About GlobalData 45
Contact Us 45
Disclaimer 45
Source 46

List of Tables
Chagas Disease (American Trypanosomiasis) Therapeutics, Global, Clinical Trials by Region, 2016* 6
Chagas Disease (American Trypanosomiasis) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8
Chagas Disease (American Trypanosomiasis) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9
Chagas Disease (American Trypanosomiasis) Therapeutics Clinical Trials, Europe, Top Countries, 2016* 10
Chagas Disease (American Trypanosomiasis) Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
Chagas Disease (American Trypanosomiasis) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 12
Proportion of Chagas Disease (American Trypanosomiasis) to Infectious Disease Clinical Trials, G7 Countries (%), 2016* 14
Chagas Disease (American Trypanosomiasis) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
Proportion of Chagas Disease (American Trypanosomiasis) to Infectious Disease Clinical Trials, E7 Countries (%), 2016* 17
Chagas Disease (American Trypanosomiasis) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
Chagas Disease (American Trypanosomiasis) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
Chagas Disease (American Trypanosomiasis) Therapeutics, Global, Clinical Trials by Phase, 2016* 20
Chagas Disease (American Trypanosomiasis) Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21
Chagas Disease (American Trypanosomiasis) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
Chagas Disease (American Trypanosomiasis) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
Chagas Disease (American Trypanosomiasis) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
Chagas Disease (American Trypanosomiasis) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25
Chagas Disease (American Trypanosomiasis) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
Chagas Disease (American Trypanosomiasis) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
Chagas Disease (American Trypanosomiasis) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28

List of Figures
Chagas Disease (American Trypanosomiasis) Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
Chagas Disease (American Trypanosomiasis) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Chagas Disease (American Trypanosomiasis) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9
Chagas Disease (American Trypanosomiasis) Therapeutics Clinical Trials, Europe, Top Countries (%), 2016* 10
Chagas Disease (American Trypanosomiasis) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 12
Proportion of Chagas Disease (American Trypanosomiasis) to Infectious Disease Clinical Trials, G7 Countries (%), 2016* 13
Chagas Disease (American Trypanosomiasis) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
Proportion of Chagas Disease (American Trypanosomiasis) to Infectious Disease Clinical Trials, E7 Countries (%), 2016* 16
Chagas Disease (American Trypanosomiasis) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
Chagas Disease (American Trypanosomiasis) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
Chagas Disease (American Trypanosomiasis) Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20
Chagas Disease (American Trypanosomiasis) Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21
Chagas Disease (American Trypanosomiasis) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
Chagas Disease (American Trypanosomiasis) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
Chagas Disease (American Trypanosomiasis) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
Chagas Disease (American Trypanosomiasis) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25
Chagas Disease (American Trypanosomiasis) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
Chagas Disease (American Trypanosomiasis) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
Chagas Disease (American Trypanosomiasis) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28
GlobalData Methodology 44

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Phototherapy Equipment Market by Type, Application, End-user, Geography - Global Forecast to 2021

Phototherapy Equipment Market by Type, Application, End-user, Geography - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global phototherapy equipment market is projected to reach USD 583.4 million by 2021, growing at a CAGR of 4.5% during the forecast period of 2016 to 2021. This market is primarily driven by the huge ...

Antinuclear Antibody Test Market by Product, Technique, Disease, End User - Forecast to 2021

Antinuclear Antibody Test Market by Product, Technique, Disease, End User - Forecast to 2021

  • $ 5650
  • Industry report
  • September 2016
  • by MarketsandMarkets

The global antinuclear antibody (ANA) testing market is expected to reach USD 1,476.1 million by 2021 from USD 823.5 million in 2016, at a CAGR of 12.4%. The global ANA testing market is segmented based ...

Interstitial Cystitis  - Market Insights, Epidemiology and Market Forecast-2023

Interstitial Cystitis  - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Interstitial Cystitis - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.